These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2830689)

  • 1. Detection of a late lymphocyte activation marker by A1, a new monoclonal antibody.
    Aversa GG; Suranyi MG; Waugh JA; Bishop AG; Hall BM
    Transplant Proc; 1988 Feb; 20(1):49-52. PubMed ID: 2830689
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen.
    Lazarovits AI; Moscicki RA; Kurnick JT; Camerini D; Bhan AK; Baird LG; Erikson M; Colvin RB
    J Immunol; 1984 Oct; 133(4):1857-62. PubMed ID: 6088627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5C6-F4, a novel 100,000-dalton rat lymphocyte activation antigen defined by monoclonal antibody.
    Uede T; Kohda H; Yuasa H; Osawa H; Diamantstein T; Yodoi J; Ishii Y; Kikuchi K
    J Immunol; 1986 Jun; 136(11):3968-76. PubMed ID: 3009613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2).
    Takei F
    J Immunol; 1985 Mar; 134(3):1403-7. PubMed ID: 2981916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody.
    Fox DA; Hussey RE; Fitzgerald KA; Acuto O; Poole C; Palley L; Daley JF; Schlossman SF; Reinherz EL
    J Immunol; 1984 Sep; 133(3):1250-6. PubMed ID: 6205075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel T cell activation antigen identified by monoclonal IMN3.1 antibody and expressed preferentially on human T cells susceptible to apoptotic cell death.
    Uehara T; Miyawaki T; Natsuume-Sakai S; Nibu R; Hasui M; Yachie A; Shimizu S; Taniguchi N
    J Immunol; 1993 Apr; 150(8 Pt 1):3243-53. PubMed ID: 7682236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody that recognizes an Ly-6-linked antigen inhibits the generation of functionally active T cell subsets.
    Flood PM; Murphy DB; Horowitz M; LeClair KP; Smith FR; Stockert E; Palladino MA; DeLeo AB
    J Immunol; 1985 Jul; 135(1):63-72. PubMed ID: 2987354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel differentiation antigen on proliferating murine thymocytes identified by a rat monoclonal antibody.
    Takei F
    J Immunol; 1984 Feb; 132(2):766-71. PubMed ID: 6418809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S152 (CD27). A modulating disulfide-linked T cell activation antigen.
    Bigler RD; Bushkin Y; Chiorazzi N
    J Immunol; 1988 Jul; 141(1):21-8. PubMed ID: 2837508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new autoreactive monoclonal antibody specific for the Thy-1 antigen.
    Rabinowitz R; Hadar R; Laskov R; Schlesinger M
    Thymus; 1986; 8(5):279-94. PubMed ID: 2879369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous cytometric analysis for the expression of cytoplasmic and surface antigens in activated T cells.
    Hayden GE; Walker KZ; Miller JF; Wotherspoon JS; Raison RL
    Cytometry; 1988 Jan; 9(1):44-51. PubMed ID: 2842118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel pathway of human T lymphocyte activation. Identification by a monoclonal antibody generated against a rheumatoid synovial T cell line.
    Higgs JB; Zeldes W; Kozarsky K; Schteingart M; Kan L; Bohlke P; Krieger K; Davis W; Fox DA
    J Immunol; 1988 Jun; 140(11):3758-65. PubMed ID: 2836500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEP 10 and VEP 13: two monoclonal antibodies raised against human large granular lymphocytes.
    Kraft D; Rumpold H; Obexer G; Böck G; Höcker P; Stemberger H
    Monogr Allergy; 1983; 18():174-7. PubMed ID: 6358865
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a murine pan-T cell antigen which is also expressed during the terminal phases of B cell differentiation.
    Gulley ML; Ogata LC; Thorson JA; Dailey MO; Kemp JD
    J Immunol; 1988 Jun; 140(11):3751-7. PubMed ID: 2897394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-CD3 monoclonal antibodies. Characterization and function].
    Bourel D; Genetet N; Merdrignac G; Genetet B
    Pathol Biol (Paris); 1987 Dec; 35(10):1285-91. PubMed ID: 3125512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2H1--a novel antigen involved in T lymphocyte triggering.
    Morimoto C; Rudd CE; Letvin NL; Hagan M; Schlossman SF
    J Immunol; 1988 Apr; 140(7):2165-70. PubMed ID: 2895150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monoclonal antibodies to the antigens of human HeLa tumor cells].
    Malakhova IV; Khizhniakova TM; Novokhatskiĭ AS
    Tsitologiia; 1986 May; 28(5):537-44. PubMed ID: 3526672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigens recognised by monoclonal anti-lymphocyte antibodies can have unexpected tissue localizations].
    Thivolet J; Schmitt D; Viac J; Brochier J
    C R Seances Acad Sci III; 1983 Feb; 296(5):203-6. PubMed ID: 6405983
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential expression of a surface antigen recognized by a monoclonal antibody, J11d, on unprimed and primed B cells.
    Pillai PS; Reynolds SD; Chace JH; Scott DW
    J Immunol; 1986 Aug; 137(3):791-7. PubMed ID: 3487587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a novel differentiation antigen complex recognize by a monoclonal antibody (A-1A5): unique activation-specific molecular forms on stimulated T cells.
    Hemler ME; Ware CF; Strominger JL
    J Immunol; 1983 Jul; 131(1):334-40. PubMed ID: 6408178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.